RADIUM-223 CHLORIDE (ALPHARADIN) IMPACT ON OVERALL SURVIVAL AND SKELETAL-RELATED EVENTS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASES: A PHASE III RANDOMIZED TRIAL (ALSYMPCA)

Authors
Publication date
1 May 2012
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Supporting member

    Queen's University Belfast Research Portal

    redirect
    oaioai:pure.qub.ac.uk/portal:publ...
    Last time updated on 09/05/2013